10 employees
Clear Vascular offers Tin-Annexin, an injectable radiopharmaceutical agent for imaging and therapy of inflammatory tissues.
2005
$5.4M
from 1 investors over 1 rounds
Clear Vascular raised $5.4M on August 9, 2010
Investors: ARCUS VENTURES LTD